Keywords: Arena Oharma, Lorcaserin, Lorquess, Eisai, Gilead Sciences, Truvada, HIV prophylaxis, PrEP, USA, FDA advisory panel

Arena Pharma gets positive FDA panel vote for obesity drug; prophylactic Truvada backed

Article | 11 May 2012

Print This

USA-based Arena Pharmaceuticals (Nasdaq: ARNA) and Japanese licensing partner Eisai (TYO: 4523) got a big boost yesterday, when the US Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in